News

Prof Amadi wins NLNG’s $100,000 prize for Science

  • Respiratory technologies for new-born adjudged best

A novel scientific work on respiratory technology for keeping newborns alive by Prof Hippolite Amadi has won this year’s edition of The Nigeria Prize for Science.

The announcement was made by the board at a news conference in Lagos.

The award was sponsored by Nigeria LNG Limited (NLNG) and it attracts a $100,000 cash prize.

Amadi is a visiting professor of Medical Engineering and Technology at Imperial College London.

The Prize’s Advisory Board, led by Prof Barth Nnaji, announced the judges’ verdict based on the 2023 theme: “Innovation for Enhancement of Healthcare Therapy” .

Reacting to the verdict, Mr. Andy Odeh, NLNG’s General Manager, External Relations and Sustainable Development, said the judges’ decision was a testament to the power of collaboration between the private sector, academia, and the broader scientific community.

He stated that the outcome emphasised the need for collective responsibility to nurture and support innovative solutions that hold the promise of transforming the country, adding that it aligns perfectly with NLNG’s vision of “helping to build a better Nigeria” where ground-breaking ideas flourish, and every life is valued and protected.

“We are honoured and deeply moved by the judges’ decision to recognise the ground-breaking innovation in respiratory technology that has been awarded the Nigeria Prize for Science in 2023.

“This invention not only represents a remarkable leap forward in medical science but also serves as a beacon of hope for the most vulnerable among us – our neonates.

“It reminds us that true progress is measured not only in scientific achievement but in the lives it touches and saves.
Read Also: 100 Days: For Otti, morning shows the day

“Today, we celebrate the impact that innovation can have in enhancing healthcare therapy and safeguarding the futures of countless new-borns”. (The Nation)

Back to top button

Discover more from Dateline Nigeria

Subscribe now to keep reading and get access to the full archive.

Continue reading